Acesion Pharma Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

Acesion Pharma General Information

Description

Developer of a biotech company intended to advance medical drugs for the treatment of atrial fibrillation. The company inhibits a type of ion channel in heart cells that is involved in generating the electrical signals that regulate the heart's rhythm and maintenance of sinus rhythm, enabling healthcare professionals with chronic treatment to prevent the recurrence of AF and maintain normal heart rhythm.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Nordre Fasanvej 215
  • 2000 Frederiksberg
  • Denmark
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Nordre Fasanvej 215
  • 2000 Frederiksberg
  • Denmark

Acesion Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Acesion Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Secondary Transaction - Private 01-Feb-2026 Completed Clinical Trials - Phase 2
9. Later Stage VC (Series B) 26-Sep-2023 Completed Clinical Trials - Phase 2
8. Later Stage VC 03-May-2019 Completed Clinical Trials - Phase 2
7. Grant 12-Mar-2019 Completed Clinical Trials - Phase 2
6. Later Stage VC 03-Nov-2016 Completed Clinical Trials - Phase 2
5. Early Stage VC 17-Dec-2014 Completed Startup
4. Grant 16-Dec-2013 Completed Startup
3. Grant 01-Dec-2013 Completed Startup
2. Early Stage VC 05-May-2013 $1.27M $1.27M Completed Startup
1. Seed Round 01-Dec-2011 Completed Startup
To view Acesion Pharma’s complete valuation and funding history, request access »

Acesion Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 8,413,590 $0.4 $0.4 1x $0.4 7.3%
Ordinary 1,407,140 $0.04 $0.04 1x $0.04 1.22%
To view Acesion Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Acesion Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotech company intended to advance medical drugs for the treatment of atrial fibrillation. The company i
Drug Discovery
Frederiksberg, Denmark
22 As of 2026

North Brunswick, NJ
 

San Leandro, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Acesion Pharma Competitors (3)

One of Acesion Pharma’s 3 competitors is Azure Biotech, a Venture Capital-Backed company based in North Brunswick, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Azure Biotech Venture Capital-Backed North Brunswick, NJ
Mercator MedSystems Venture Capital-Backed San Leandro, CA
Elixir Medical Venture Capital-Backed Milpitas, CA
You’re viewing 3 of 3 competitors. Get the full list »

Acesion Pharma Patents

Acesion Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4805343-A1 Highly soluble salts Pending 09-Nov-2023
WO-2025099044-A1 Highly soluble salts Inactive 09-Nov-2023
EP-4245753-A1 Imidazole derivatives as potassium channel inhibitors Inactive 17-Mar-2022
EP-4493546-A1 Imidazole derivatives as potassium channel inhibitors Active 17-Mar-2022
EP-4493546-B1 Imidazole derivatives as potassium channel inhibitors Active 17-Mar-2022 C07D233/88
To view Acesion Pharma’s complete patent history, request access »

Acesion Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acesion Pharma Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alpha Wave Global Growth/Expansion Minority
Canaan Partners Venture Capital Minority
Global BioAccess Fund Venture Capital Minority
KB Investment Venture Capital Minority
Fontus Capital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Acesion Pharma FAQs

  • When was Acesion Pharma founded?

    Acesion Pharma was founded in 2011.

  • Where is Acesion Pharma headquartered?

    Acesion Pharma is headquartered in Frederiksberg, Denmark.

  • What is the size of Acesion Pharma?

    Acesion Pharma has 22 total employees.

  • What industry is Acesion Pharma in?

    Acesion Pharma’s primary industry is Drug Discovery.

  • Is Acesion Pharma a private or public company?

    Acesion Pharma is a Private company.

  • What is Acesion Pharma’s current revenue?

    The current revenue for Acesion Pharma is .

  • How much funding has Acesion Pharma raised over time?

    Acesion Pharma has raised $71.6M.

  • Who are Acesion Pharma’s investors?

    Alpha Wave Global, Canaan Partners, Global BioAccess Fund, KB Investment, and Fontus Capital are 5 of 7 investors who have invested in Acesion Pharma.

  • Who are Acesion Pharma’s competitors?

    Azure Biotech, Mercator MedSystems, and Elixir Medical are competitors of Acesion Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process